Can This AI Stock Bounce Back in 2026?
Artificial intelligence (AI) is all the rage on Wall Street these days, but not every AI stock is equally successful. Some of the bigger names in the field, like Nvidia, have seen their shares soar in recent years, while other, smaller ones, like Recursion Pharmaceuticals (NASDAQ: RXRX), continue to struggle.
Recursion, a healthcare-focused AI company, could have some catalysts in the next 12 to 18 months, however. Can the stock bounce back this year?
Image source: Getty Images.
Source Fool.com
